Back

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

20 May 2025 (08:40 - 08:50)
Organised by: Logo
Congress Presentation Part of: Latest registries and observational studies Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Kristian Berge

Akershus University Hospital - AHUS, Nordbyhagen (Norway)

6 More presentations in this session

Presentation thumbnail
Discussant panel
Presentation thumbnail
Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence
Doctor F. Lindberg (Stockholm, SE)
Slides Video
Presentation thumbnail
Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry
Doctor R. Inciardi (Brescia, IT)
Slides Video
Presentation thumbnail
Timing of cardiac resynchronization therapy after optimal medical therapy in patients with heart failure: temporal trends, predictors and association with outcomes
Doctor A. Villaschi (Milan, IT)
Slides Video
Presentation thumbnail
Cardiac resynchronization therapy in heart failure: a target trial emulation study
Doctor C. Basile (Stockholm, SE)
Slides Video

Access the full session

Session thumbnail
Latest registries and observational studies
Video

The Event

Event poster

Heart Failure 2025

20 May 2025 08:40 CET
You may be interested in
thumbnail
Congress Session
Strategies for better outcomes in heart failure
thumbnail
Congress Session
Improvement of heart failure care through data
thumbnail
Congress Presentation
ESC Heart Failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources